HROWNasdaqPharmaceutical PreparationsFiscal year ends December 31
HARROW, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$27.68+0.40 (+1.47%)
Close on Oct 19, 2026
- Market cap
- $1.03B
- P/E (TTM)
- –
- Dividend yield
- –
HARROW, INC. balance sheet
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 73.3%
- Operating margin
- -1.0%
- Net margin
- -13.5%
- Return on equity, FY2025
- -8.4%
Financial strength
- Current ratio
- 2.24
- Debt to equity
- 19.24
- Debt to assets
- 70.1%
- Cash to current liabilities
- 82.1%
Valuation
- P/E ratio
- –
- Price to sales
- 3.75
- Price to book
- 68.02
- Dividend yield
- –